HEALTH

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Retrieved on: 
Mercoledì, Maggio 29, 2024
Security (finance), Calendar, HEALTH, Form, Notice

The Notice indicates that the Company must, no later than July 22, 2024, submit a plan to regain compliance with respect to the filing requirement.

Key Points: 
  • The Notice indicates that the Company must, no later than July 22, 2024, submit a plan to regain compliance with respect to the filing requirement.
  • Following receipt of such plan, Nasdaq may grant an extension of up to 180 calendar days from the Form 10-Q due date, or until November 18, 2024, for the Company to regain compliance.
  • The Notice has no immediate effect on the listing or trading of the Company’s common stock, although there can be no assurances that further delays in the filing of the Form 10-Q will not have an impact on the listing or trading of the Company’s common stock.
  • While the Company can provide no assurances as to timing, the Company is working diligently and plans to file the Form 10-Q as soon as practicable to regain compliance with the Listing Rule.

Shining at the Vitafoods Europe 2024, BioGrowing's Weizmannia Coagulans BC-G44 Attracts Attention

Retrieved on: 
Venerdì, Maggio 17, 2024
SAFETY, Dentistry, 5S, Milk, Intellectual property, Professional, Powder, APEC, Fermentation, HEALTH, Constipation, Health, Carbon, Coffee, Speech, Research, IP, Attention, Exhibition, Communication, Probiotic, Temperature, European, Dietary supplement

The design was simple yet sophisticated, with the highlight being the BioGrowing's proprietary IP "Xiao Junren" character, which attracted the attention of many visitors.

Key Points: 
  • The design was simple yet sophisticated, with the highlight being the BioGrowing's proprietary IP "Xiao Junren" character, which attracted the attention of many visitors.
  • BioGrowing is dedicated to providing customers with probiotic raw materials, ODM/CDMO, Starter Cultures, total solutions, and services.
  • Weizmannia coagulans BC-G44, the star strain independently developed by BioGrowing, received widespread attention from customers upon its release.
  • They possess a repository of over 4,000 probiotic strains with independent intellectual property rights, out of which more than 50 strains are commercially viable.

XEALTH CLIENT THOUGHT LEADERS AT REUTERS EVENTS DIGITAL HEALTH 2024

Retrieved on: 
Martedì, Maggio 14, 2024
Digital health, Patient, HEALTH, Digital, SAN, Assistant, Caregiver, Scripps Health, Reuters, DIGITAL, Management

SAN DIEGO, Calif.—REUTERS EVENTS DIGITAL HEALTH, May 14, 2024 (GLOBE NEWSWIRE) -- Xealth , the leader in enabling digital health at scale, is proud to support several clients who will be speaking at Reuters Events Digital Health 2024 .

Key Points: 
  • SAN DIEGO, Calif.—REUTERS EVENTS DIGITAL HEALTH, May 14, 2024 (GLOBE NEWSWIRE) -- Xealth , the leader in enabling digital health at scale, is proud to support several clients who will be speaking at Reuters Events Digital Health 2024 .
  • With the theme “Innovate, automate, and become the go-to care partner,” Digital Health 2024 will be held May 14-15 in San Diego, Calif.
  • Title: Because technology is only as good as those that use it; getting the change management process right
    Cindy Gipson, Assistant Vice President, Growth & Accountable Care Enterprise, Scripps Health
    “Care delivery is going through a transformation, including leveraging digital to fill gaps and assist with staff shortages, outcomes and efficiencies,” said Mike McSherry, CEO and co-founder of Xealth.
  • “Xealth partners with many of the country’s leading health systems to automate digital health and bring them into current workflows, making them more accessible and simpler to use for engaging patients, which benefits all involved – patients, caregivers, providers and healthcare organizations.”
    Xealth has sent more than 12 million digital assets from about 100,000 providers across many of the largest U.S. health systems.

Muse Health Announces Strategic Partnership With Welcome Tech

Retrieved on: 
Lunedì, Maggio 13, 2024
Partnership, Health, Patient, HEALTH, Tech, Multimedia, Nursing

DALLAS, May 13, 2024 /PRNewswire-PRWeb/ -- Muse Health, LLC, a recognized leader in BIPOC healthcare services, today announced a strategic partnership with Welcome Tech, a technology and services platform that accelerates success for immigrant households. Through comprehensive engagement and health management solutions, the partnership expands Welcome Tech's offering of community resources while creating more efficient operations and reducing customer costs for providers and health plans.

Key Points: 
  • DALLAS, May 13, 2024 /PRNewswire-PRWeb/ -- Muse Health, LLC, a recognized leader in BIPOC healthcare services, today announced a strategic partnership with Welcome Tech, a technology and services platform that accelerates success for immigrant households.
  • Through comprehensive engagement and health management solutions, the partnership expands Welcome Tech's offering of community resources while creating more efficient operations and reducing customer costs for providers and health plans.
  • Muse Health will deliver digital content through Welcome Tech's network of 50+ consulates and embassies and assist growing Welcome Tech's bundled health care subscription, reaching over 10 million immigrant community members and helping health plans better engage with BIPOC users.
  • We are thrilled to offer our community Muse Health care solutions, with the goal of advancing better health outcomes for underserved populations," says Amir Hemmat, CEO of Welcome Tech.

Vesica Health Announces Launch of AssureMDx Test to Improve Bladder Cancer Detection

Retrieved on: 
Venerdì, Maggio 3, 2024
Health, HEALTH, Standard of care, Patient, Bladder cancer, Hematuria, MPH, Physician

IRVINE, Calif., May 3, 2024 /PRNewswire/ -- VESICA HEALTH, INC., a leading multi-omics liquid biopsy company dedicated to improving the management of hematuria patients and the early detection of bladder cancer, today announced the launch of its laboratory-developed AssureMDx™ test.

Key Points: 
  • IRVINE, Calif., May 3, 2024 /PRNewswire/ -- VESICA HEALTH, INC., a leading multi-omics liquid biopsy company dedicated to improving the management of hematuria patients and the early detection of bladder cancer, today announced the launch of its laboratory-developed AssureMDx™ test.
  • Christopher Thibodeau, Chief Executive Officer of Vesica Health, expressed his enthusiasm, stating, "We are delighted to officially introduce AssureMDx for patient testing.
  • Laura Caba, MPH, President of Vesica Health, underscored the significance of this innovation, declaring, "We are reshaping the landscape of early bladder cancer detection and fulfilling our commitment to elevating patient care and clinical outcomes."
  • AssureMDx represents a significant leap forward in bladder cancer diagnostics, offering unparalleled accuracy and reliability backed by rigorous scientific validation.

TIME Reveals the Inaugural TIME100 Health List of the World's Most Influential People in Health

Retrieved on: 
Giovedì, Maggio 2, 2024
Cancer, EVP, CDC, Bionics, Eli Lilly, Medicaid, Migrant Clinicians Network, Podcast, TIME, Future, Novo Nordisk, HEALTH, Medicare, Eli Lilly and Company, Apple, Letter, AstraZeneca, Woman, Northwell Health

--See the complete 2024 TIME100 Health list: time.com/time100health --See the TIME100 Health cover featuring an illustration by Peter Greenwood for TIME: https://bit.ly/3Uojcso 

Key Points: 
  • NEW YORK, May 2, 2024 /PRNewswire/ -- Today, TIME reveals the inaugural TIME100 Health list recognizing the 100 most influential individuals in health.
  • Health innovation, like this list, reflects humanity at its best: people using all their resourcefulness and ingenuity to help one another live better….
  • The youngest individual recognized on the inaugural TIME100 Health list is 28-year-old Dale Whelehan, CEO of Four Day Week Global.
  • See the full 2024 TIME100 Health list here: time.com/time100health
    TIME will convene the TIME100 Impact Dinner: Leaders Shaping the Future of Health to spotlight an array of leaders including those featured on the new TIME100 Health list of 100 individuals on May 13th in New York City.

Green Box Unveils Dynamic Lineup for 16th Annual Arts Festival

Retrieved on: 
Giovedì, Aprile 25, 2024
Imagination, Russell Hall, Grammy Awards, EAD, Tap dance, CO, Pulitzer, En plein air, Friends, Block Party, Nimbus, The Kid, Festival, Ink brush, Green box, Art, Ensemble, Pulitzer Prize, MUSIC, Oil lamp, Health, Balkan Beat Box, Collection, House, Dance, HEALTH, Music, Bass, The New York Times, Master class, Junkie, Kid, Astronomy, Yoga, National Book Award, African Americans, Distillation, Creativity, Elder, Nightclub

Green Mountain Falls, CO, April 25, 2024 (GLOBE NEWSWIRE) -- Green Box is thrilled to announce the much anticipated 16th Annual Green Box Arts Festival, scheduled to take place from July 1 to July 14, 2024, in Green Mountain Falls, Colorado.

Key Points: 
  • Green Mountain Falls, CO, April 25, 2024 (GLOBE NEWSWIRE) -- Green Box is thrilled to announce the much anticipated 16th Annual Green Box Arts Festival, scheduled to take place from July 1 to July 14, 2024, in Green Mountain Falls, Colorado.
  • "The 16th Annual Green Box Arts Festival promises to be our most diverse and exhilarating yet,” says Scott RC Levy, Executive Director of Green Box.
  • Embrace health and well-being at this year's Green Box Arts Festival, where offerings catering to mind, body, and spirit have been expanded.
  • The Green Box Arts Festival Box Office opens in-person and online on Wednesday, May 15th.

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

Retrieved on: 
Martedì, Aprile 23, 2024
Annual report, Security (finance), Notice, Form, HEALTH

TAMPA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on April 17, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that because the Company had not yet filed its Annual Report on Form 10-K for the 2023 fiscal year (the “Form 10-K”), the Company was not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.

Key Points: 
  • TAMPA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (Nasdaq: MEDS) (the “Company”), announced that, on April 17, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (“Nasdaq”) indicating that because the Company had not yet filed its Annual Report on Form 10-K for the 2023 fiscal year (the “Form 10-K”), the Company was not compliant with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.
  • The Notice had no immediate effect on the listing or trading of the Company’s common stock.
  • The Notice indicated that the Company must, no later than June 17, 2024, submit a plan to regain compliance with respect to the filing requirement.
  • On April 22, 2024, the Company filed the Form 10-K with the Securities and Exchange Commission, and, as a result of that filing the Company believes it has regained compliance with the Listing Rule.

GeBBS Healthcare Solutions Acquires CCD Health

Retrieved on: 
Venerdì, Aprile 26, 2024
Dominican, Revenue cycle management, Health, CCD, Health care, Partnership, RCM, Family, Acquisition, HEALTH, Health insurance

LOS ANGELES, April 26, 2024 /PRNewswire-PRWeb/ -- GeBBS Healthcare Solutions, Inc.(ChrysCapital portfolio company) a leading provider of technology enabled Revenue Cycle Management (RCM) & Risk Adjustment Solutions for Healthcare Providers and Payers, announced the acquisition of CCD Health, a Dominican Republic  based provider of  Patient Experience Services.

Key Points: 
  • LOS ANGELES, April 26, 2024 /PRNewswire-PRWeb/ -- GeBBS Healthcare Solutions, Inc.(ChrysCapital portfolio company) a leading provider of technology enabled Revenue Cycle Management (RCM) & Risk Adjustment Solutions for Healthcare Providers and Payers, announced the acquisition of CCD Health, a Dominican Republic based provider of  Patient Experience Services.
  • CCD Health clients will benefit from GeBBS' end-to-end revenue cycle management services, workflow/automation tools and large geographic footprint.
  • "We're excited to announce our partnership with CCD Health, marking a significant stride in bolstering our patient contact services," stated Milind Godbole, CEO and Managing Director of GeBBS Healthcare Solutions.
  • "We are proud to announce that CCD Health will join forces and integrate into the renowned GeBBS organization.

AYLO HEALTH OPENS SECOND PRIMARY CARE LOCATION IN NORTH ATLANTA

Retrieved on: 
Martedì, Marzo 19, 2024
Patient, House, Marketing, X-ray, Physician, HEALTH, Practitioner, Nursing

KENNESAW, Ga., March 19, 2024 /PRNewswire/ -- Aylo Health, the medical group known for their mission to redefine healthcare, has announced the upcoming opening of their second primary care office in six months in the North Metro Atlanta area. Following the successful launch of Aylo Health's initial North Metro primary care office in Canton, the organization is expanding their footprint to Kennesaw, located at 2085 Mack Dobbs Road Northwest.

Key Points: 
  • NEW AYLO HEALTH - PRIMARY CARE AT KENNESAW LOCATION HOSTING OPEN HOUSE ON THURSDAY APRIL 11TH, FROM 4 – 7PM
    KENNESAW, Ga., March 19, 2024 /PRNewswire/ -- Aylo Health, the medical group known for their mission to redefine healthcare, has announced the upcoming opening of their second primary care office in six months in the North Metro Atlanta area.
  • Offering primary care that prioritizes patient needs and schedules is a novel concept in healthcare that Aylo Health brings with it into every new community.
  • The new Aylo Health - Primary Care at Kennesaw will offer extended hours, weekend appointments, in-house labs, x-rays, and imaging services to best serve their patients.
  • For more information about Aylo Health Primary Care at Kennesaw, including how to book appointments online, visit https://aylohealth.com/location/north-atlanta/primary-care-at-kennesaw/ where you can sign up to learn more.